Developer docs
API playgroundTry for free, no card

Search company profiles

Centroderm

Full company profile

uuid000eiv1

Namestring
Centroderm
Legal namestring
Centroderm GmbH
Websiteurl
centroderm.de
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Centroderm GmbH is a German private limited company headquartered in Wuppertal that operates a specialized dermatology clinic and clinical trial site. The firm offers clinical dermatology services to patients — including laser treatments and operative dermatology — under the leadership of founder and Chief Doctor Thomas Dirschka. In parallel, Centroderm has positioned itself as a contract clinical trial site for pharmaceutical and biotechnology sponsors developing dermatological therapeutics, providing patient enrollment, in-study clinical procedures, and regulatory-compliant data collection.

The company's core business activity is performing as a clinical research site. Its Wuppertal facility has completed the regulatory requirements and medical team training necessary to conduct Phase 2b dermatology studies, and was selected as the trial site for Vidac Pharma Holdings PLC's Phase 2b study of VDA-1102 topical ointment for highly proliferative Actinic Keratosis lesions. The core technology is specialized dermatology clinical research infrastructure: trained investigators, GCP-compliant processes, and patient access for skin-condition trials. There is no disclosed proprietary software, platform, or technology stack beyond standard clinical trial operations.

Centroderm's revenue model is professional services. Fees for clinical trial site operations are negotiated on a per-study basis with pharmaceutical sponsors, with pricing not publicly disclosed. The go-to-market motion is enterprise field sales — driven by industry reputation and regulatory credentials rather than broad marketing — targeting pharmaceutical and biotech companies as the primary customer segment. With 11-50 employees and a single site, Centroderm is a small specialist operator combining a patient-facing dermatology practice with a niche B2B contract research capability.

Short descriptiontext

Centroderm GmbH is a Wuppertal-based dermatology clinic and clinical trial site that provides clinical dermatology, laser treatments, and operative dermatology to patients, and serves pharmaceutical sponsors as a Phase 2 dermatology trial site.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWuppertal, Germany
HQ citystring
Wuppertal
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dermatology clinical trials, laser dermatology, actinic keratosis research, clinical research services, operative dermatology
Industry2 codes
PRIMARYHLAKACAA
General & Medical Dermatology
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Medical Laboratories8071
Product category
Dermatology Services and Clinical Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services
TypeProfessional Services
Description

Centroderm GmbH provides clinical trial site services for pharmaceutical companies conducting dermatology research. Revenue is generated through conducting patient enrollment, clinical procedures, and data collection for Phase 2 clinical studies.

einpresswire.com
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Centroderm is a dermatology clinic and clinical trial site headquartered in Wuppertal, Germany. It delivers dermatology consultations and treatments, laser dermatology, and operative dermatology procedures to patients, and provides sponsor-facing clinical research services — including principal investigator oversight and patient recruitment — for dermatology drug development programs. The site has been selected to run contracted clinical studies such as the Vidac Pharma Phase 2b trial of VDA-1102 in actinic keratosis.

Differentiator
Functional benefit
Problem solved
Product and service4 records
1Dermatology consultation and treatment
CategoryDermatology services
Description

Diagnostic and therapeutic dermatology services delivered to patients at Centroderm's clinic in Wuppertal, Germany, covering skin conditions and general dermatologic care.

2Laser dermatology treatments
CategoryDermatology services
Description

Laser-based dermatology procedures provided to patients at Centroderm's clinic for skin-related indications, delivered as part of the practice's treatment offerings.

3Operative dermatology
CategoryDermatology services
Description

Surgical dermatology procedures performed on patients at Centroderm's clinic as part of its on-site dermatology service offering.

4Clinical trial site services for dermatology studies
CategoryClinical research services
Description

Contracted clinical research services sold to pharmaceutical and biotech sponsors, including acting as an investigator site, principal investigator oversight, and patient recruitment for dermatology clinical trials.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-23
Description

Vidac Pharma Holdings PLC partnered with Centroderm GmbH to conduct a Phase 2b clinical study evaluating VDA-1102 for highly proliferative Actinic Keratosis lesions. Centroderm's facility in Wuppertal, Germany was selected following completion of regulatory requirements and training of the medical team. This partnership supports Vidac's clinical development planning and may inform the design of a potential Phase 3 registration study.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Dermatest
TypeDirect peer
Description

Dermatest is a German dermatological research institute that conducts clinical studies for cosmetics, pharmaceuticals, and medical devices on skin. It directly parallels Centroderm's dermatology clinical research activities in the German market.

TypeBroad incumbent
Description

Parexel is a major global CRO offering dermatology clinical development services across multiple geographies and phases. It represents the established, large-scale alternative for sponsors seeking dermatology trial execution.

TypeBroad incumbent
Description

ICON is a global CRO with extensive dermatology and Phase 2/3 site operations worldwide. As a broad incumbent, it competes for dermatology sponsor work that Centroderm would otherwise target, particularly for multi-country studies.

TypeBroad incumbent
Description

IQVIA is a global CRO with dermatology clinical trial capabilities and a broad site network. It represents the large, multi-geography incumbent alternative to specialty sites like Centroderm for sponsors running multi-site dermatology programs.

TypeDirect peer
Description

Bioskin is a dermatology-focused CRO offering Phase I-IV clinical trials and laboratory services for skin therapeutics, headquartered in Germany. It competes directly with Centroderm for dermatology clinical trial contracts from pharmaceutical sponsors.

TypeBroad incumbent
Description

Charles River provides clinical research services including dermatology trial support through its early-stage and site-services network. It is comparable as a broad life-sciences services incumbent serving pharmaceutical dermatology pipelines.

TypeEmerging player
Description

Medicover operates clinical research sites and healthcare facilities across Central and Eastern Europe, including dermatology offerings. It overlaps with Centroderm as a regionally-focused clinical trial operator, though at a larger multi-site scale.

8proDERM
TypeDirect peer
Description

proDERM is a Hamburg-based dermatology-focused contract research organization offering clinical trials and testing services for skin care products and pharmaceuticals. It is the most direct comparable to Centroderm as a Germany-based dermatology-specialized clinical trial site serving pharmaceutical sponsors.

TypeRegional player
Description

German university hospital dermatology departments (e.g., Charité Berlin, Universitätsklinikum Würzburg) conduct Phase 2/3 dermatology trials as academic centers. They represent an alternative sponsor site option, competing with Centroderm on academic credibility and patient pool, though with different operating economics.

TypeBroad incumbent
Description

SGS offers clinical research and bioanalytical laboratory services for pharmaceutical clients including dermatology studies. It is comparable as a broad life-sciences services provider capable of running dermatology clinical programs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centroderm

Dermatology Services and Clinical Researchcentroderm.de

Centroderm GmbH is a Wuppertal-based dermatology clinic and clinical trial site that provides clinical dermatology, laser treatments, and operative dermatology to patients, and serves pharmaceutical sponsors as a Phase 2 dermatology trial site.

What Centroderm does

Centroderm GmbH is a German private limited company headquartered in Wuppertal that operates a specialized dermatology clinic and clinical trial site. The firm offers clinical dermatology services to patients — including laser treatments and operative dermatology — under the leadership of founder and Chief Doctor Thomas Dirschka. In parallel, Centroderm has positioned itself as a contract clinical trial site for pharmaceutical and biotechnology sponsors developing dermatological therapeutics, providing patient enrollment, in-study clinical procedures, and regulatory-compliant data collection.

The company's core business activity is performing as a clinical research site. Its Wuppertal facility has completed the regulatory requirements and medical team training necessary to conduct Phase 2b dermatology studies, and was selected as the trial site for Vidac Pharma Holdings PLC's Phase 2b study of VDA-1102 topical ointment for highly proliferative Actinic Keratosis lesions. The core technology is specialized dermatology clinical research infrastructure: trained investigators, GCP-compliant processes, and patient access for skin-condition trials. There is no disclosed proprietary software, platform, or technology stack beyond standard clinical trial operations.

Centroderm's revenue model is professional services. Fees for clinical trial site operations are negotiated on a per-study basis with pharmaceutical sponsors, with pricing not publicly disclosed. The go-to-market motion is enterprise field sales — driven by industry reputation and regulatory credentials rather than broad marketing — targeting pharmaceutical and biotech companies as the primary customer segment. With 11-50 employees and a single site, Centroderm is a small specialist operator combining a patient-facing dermatology practice with a niche B2B contract research capability.

Centroderm firmographics

Firmographics
Name
Centroderm
Legal name
Centroderm GmbH
Website
https://centroderm.de
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Centroderm GmbH is a Wuppertal-based dermatology clinic and clinical trial site that provides clinical dermatology, laser treatments, and operative dermatology to patients, and serves pharmaceutical sponsors as a Phase 2 dermatology trial site.
Ownership category
akta.pro rank

Centroderm industry classification

Industry
Product category
Dermatology Services and Clinical Research
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAKACAA
General & Medical Dermatology
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories

Keywords

  • Dermatology clinical trials
  • Laser dermatology
  • Actinic keratosis research
  • Clinical research services
  • Operative dermatology

Where Centroderm is headquartered

Location

Headquarters

HQ city
Wuppertal
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Centroderm business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial Services: Centroderm GmbH provides clinical trial site services for pharmaceutical companies conducting dermatology research. Revenue is generated through conducting patient enrollment, clinical procedures, and data collection for Phase 2 clinical studies.

Go-to-market motion1 record

Centroderm product offering

Product offering

Core offering

Centroderm is a dermatology clinic and clinical trial site headquartered in Wuppertal, Germany. It delivers dermatology consultations and treatments, laser dermatology, and operative dermatology procedures to patients, and provides sponsor-facing clinical research services — including principal investigator oversight and patient recruitment — for dermatology drug development programs. The site has been selected to run contracted clinical studies such as the Vidac Pharma Phase 2b trial of VDA-1102 in actinic keratosis.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dermatology consultation and treatment Diagnostic and therapeutic dermatology services delivered to patients at Centroderm's clinic in Wuppertal, Germany, covering skin conditions and general dermatologic care.
  • Laser dermatology treatments Laser-based dermatology procedures provided to patients at Centroderm's clinic for skin-related indications, delivered as part of the practice's treatment offerings.
  • Operative dermatology Surgical dermatology procedures performed on patients at Centroderm's clinic as part of its on-site dermatology service offering.
  • Clinical trial site services for dermatology studies Contracted clinical research services sold to pharmaceutical and biotech sponsors, including acting as an investigator site, principal investigator oversight, and patient recruitment for dermatology clinical trials.

Companies that use Centroderm

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Centroderm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Centroderm partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Vidac Pharma Holdings PLCcoreStrategic or Co-development Partner · 23 February 2026Vidac Pharma Holdings PLC partnered with Centroderm GmbH to conduct a Phase 2b clinical study evaluating VDA-1102 for highly proliferative Actinic Keratosis lesions. Centroderm's facility in Wuppertal, Germany was selected following completion of regulatory requirements and training of the medical team. This partnership supports Vidac's clinical development planning and may inform the design of a potential Phase 3 registration study.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Centroderm competitors and assessment

Company assessment

Direct peers

  • Dermatest: Dermatest is a German dermatological research institute that conducts clinical studies for cosmetics, pharmaceuticals, and medical devices on skin. It directly parallels Centroderm's dermatology clinical research activities in the German market.
  • Bioskin: Bioskin is a dermatology-focused CRO offering Phase I-IV clinical trials and laboratory services for skin therapeutics, headquartered in Germany. It competes directly with Centroderm for dermatology clinical trial contracts from pharmaceutical sponsors.
  • proDERM: proDERM is a Hamburg-based dermatology-focused contract research organization offering clinical trials and testing services for skin care products and pharmaceuticals. It is the most direct comparable to Centroderm as a Germany-based dermatology-specialized clinical trial site serving pharmaceutical sponsors.

Broad incumbents

  • Parexel: Parexel is a major global CRO offering dermatology clinical development services across multiple geographies and phases. It represents the established, large-scale alternative for sponsors seeking dermatology trial execution.
  • ICON plc: ICON is a global CRO with extensive dermatology and Phase 2/3 site operations worldwide. As a broad incumbent, it competes for dermatology sponsor work that Centroderm would otherwise target, particularly for multi-country studies.
  • IQVIA: IQVIA is a global CRO with dermatology clinical trial capabilities and a broad site network. It represents the large, multi-geography incumbent alternative to specialty sites like Centroderm for sponsors running multi-site dermatology programs.
  • Charles River Laboratories: Charles River provides clinical research services including dermatology trial support through its early-stage and site-services network. It is comparable as a broad life-sciences services incumbent serving pharmaceutical dermatology pipelines.
  • SGS Health Sciences: SGS offers clinical research and bioanalytical laboratory services for pharmaceutical clients including dermatology studies. It is comparable as a broad life-sciences services provider capable of running dermatology clinical programs.

Emerging players

  • Medicover: Medicover operates clinical research sites and healthcare facilities across Central and Eastern Europe, including dermatology offerings. It overlaps with Centroderm as a regionally-focused clinical trial operator, though at a larger multi-site scale.

Regional players

  • Universitätsklinikum Dermatologie (University Hospital Dermatology Departments): German university hospital dermatology departments (e.g., Charité Berlin, Universitätsklinikum Würzburg) conduct Phase 2/3 dermatology trials as academic centers. They represent an alternative sponsor site option, competing with Centroderm on academic credibility and patient pool, though with different operating economics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Centroderm social profiles

Digital presence

Centroderm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centroderm leadership team

Management profile

Number of profiles

Profiles1 record

Centroderm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centroderm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centroderm

What does Centroderm do?

Centroderm is a dermatology clinic and clinical trial site headquartered in Wuppertal, Germany. It delivers dermatology consultations and treatments, laser dermatology, and operative dermatology procedures to patients, and provides sponsor-facing clinical research services — including principal investigator oversight and patient recruitment — for dermatology drug development programs. The site has been selected to run contracted clinical studies such as the Vidac Pharma Phase 2b trial of VDA-1102 in actinic keratosis.

Is Centroderm a public or private company?

Centroderm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Centroderm founded?

Centroderm was founded in -1. It employs 11 to 50 people.

Where is Centroderm based?

Centroderm is headquartered in Wuppertal, Germany, in the Europe region.

How does Centroderm make money?

One revenue line is on record: clinical Trial Services.

Who are Centroderm's main competitors?

Direct peers on record are Dermatest, Bioskin and proDERM. Broad incumbents are Parexel, ICON plc, IQVIA, Charles River Laboratories and SGS Health Sciences. Medicover is listed as an emerging player. Universitätsklinikum Dermatologie (University Hospital Dermatology Departments) is listed as a regional player.

Does Centroderm have an API?

No public API is recorded for Centroderm.

What industry is Centroderm in?

Centroderm's product category is Dermatology Services and Clinical Research. Its primary akta.pro industry code is HLAKACAA, General & Medical Dermatology, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales